Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer's Disease

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Oct 23

PMID 34685737

Citations 3

Authors

Chuan Qin

Yongning Li

KeWei Wang

Affiliations

Soon will be listed here.

Abstract

Stem cell therapy improves memory loss and cognitive deficits in animal models with Alzheimer's disease. The underlying mechanism remains to be determined, but it may involve the interaction of stem cells with hippocampal cells. The transplantation of stem cells alters the pathological state and establishes a novel balance based on multiple signaling pathways. The new balance mechanism is regulated by various autocrine and paracrine cytokines, including signal molecules that target (a) cell growth and death. Stem cell treatment stimulates neurogenesis and inhibits apoptosis, which is regulated by the crosstalk between apoptosis and autophagy-(b) Aβ and tau pathology. Aberrant Aβ plaques and neurofibrillary tau tangles are mitigated subsequent to stem cell intervention-(c) inflammation. Neuroinflammation in the lesion is relieved, which may be related to the microglial M1/M2 polarization-(d) immunoregulation. The transplanted stem cells modulate immune cells and shape the pathophysiological roles of immune-related genes such as TREM2, CR1, and CD33-(e) synaptogenesis. The functional reconstruction of synaptic connections can be promoted by stem cell therapy through multi-level signaling, such as autophagy, microglial activity, and remyelination. The regulation of new balance mechanism provides perspective and challenge for the treatment of Alzheimer's disease.

Citing Articles

Targeting autophagy in Alzheimer's disease: Animal models and mechanisms.

Zhang X, Zhu X, Tang D, Lu J Zool Res. 2023; 44(6):1132-1145.

PMID: 37963840 PMC: 10802106. DOI: 10.24272/j.issn.2095-8137.2023.294.

New Technologies Based on Stem Cell-Therapies in Regenerative Medicine and Reproductive Biology.

Kurpisz M Cells. 2023; 12(1).

PMID: 36611889 PMC: 9818191. DOI: 10.3390/cells12010095.

Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality.

Qin C, Wang K, Zhang L, Bai L Animal Model Exp Med. 2022; 5(1):15-26.

PMID: 35229995 PMC: 8879630. DOI: 10.1002/ame2.12207.

References

Lampron A, Pimentel-Coelho P, Rivest S . Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration. J Comp Neurol. 2013; 521(17):3863-76. DOI: 10.1002/cne.23363. View

Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger P . The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008; 118(6):2190-9. PMC: 2391284. DOI: 10.1172/JCI33585. View

Marsh S, Abud E, Lakatos A, Karimzadeh A, Yeung S, Davtyan H . The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A. 2016; 113(9):E1316-25. PMC: 4780638. DOI: 10.1073/pnas.1525466113. View

Zhu X, Raina A, Rottkamp C, Aliev G, Perry G, Boux H . Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem. 2001; 76(2):435-41. DOI: 10.1046/j.1471-4159.2001.00046.x. View

Li G, Larson E, Sonnen J, Shofer J, Petrie E, Schantz A . Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology. 2007; 69(9):878-85. DOI: 10.1212/01.wnl.0000277657.95487.1c. View

Yu S, Hei Y, Liu W . Upregulation of seladin-1 and nestin expression in bone marrow mesenchymal stem cell transplantation via the ERK1/2 and PI3K/Akt signaling pathways in an Alzheimer's disease model. Oncol Lett. 2018; 15(5):7443-7449. PMC: 5920825. DOI: 10.3892/ol.2017.7543. View

Tanzi R, St George-Hyslop P, Gusella J . Molecular genetic approaches to Alzheimer's disease. Trends Neurosci. 1989; 12(4):152-8. DOI: 10.1016/0166-2236(89)90055-6. View

Pisa D, Alonso R, Rabano A, Rodal I, Carrasco L . Different Brain Regions are Infected with Fungi in Alzheimer's Disease. Sci Rep. 2015; 5:15015. PMC: 4606562. DOI: 10.1038/srep15015. View

Naaldijk Y, Jager C, Fabian C, Leovsky C, Bluher A, Rudolph L . Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice. Neuropathol Appl Neurobiol. 2016; 43(4):299-314. DOI: 10.1111/nan.12319. View

10.

Lively S, Schlichter L . Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10). Front Cell Neurosci. 2018; 12:215. PMC: 6066613. DOI: 10.3389/fncel.2018.00215. View

11.

Klein R, Mahlberg N, Ohren M, Ladwig A, Neumaier B, Graf R . The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke. J Neuroimmune Pharmacol. 2016; 11(4):708-720. DOI: 10.1007/s11481-016-9694-5. View

12.

Liu Z, Wang C, Wang X, Xu S . Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease. Cell Physiol Biochem. 2015; 37(1):321-30. DOI: 10.1159/000430356. View

13.

Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E . Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. EMBO Mol Med. 2020; 12(3):e10606. PMC: 7059012. DOI: 10.15252/emmm.201910606. View

14.

Yew D, Li W, Webb S, Lai H, Zhang L . Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison. Exp Gerontol. 1999; 34(1):117-33. DOI: 10.1016/s0531-5565(98)00017-5. View

15.

Orejana L, Barros-Minones L, Aguirre N, Puerta E . Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Exp Gerontol. 2013; 48(6):565-71. DOI: 10.1016/j.exger.2013.03.001. View

16.

Guillot-Sestier M, Doty K, Gate D, Rodriguez Jr J, Leung B, Rezai-Zadeh K . Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. 2015; 85(3):534-48. PMC: 4352138. DOI: 10.1016/j.neuron.2014.12.068. View

17.

Petukhova E, Mukhamedshina Y, Salafutdinov I, Garanina E, Kaligin M, Leushina A . Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2019; 69(2):443-453. DOI: 10.3233/JAD-190150. View

18.

Zhang Y, He M . Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice. Brain Res. 2017; 1677:86-92. DOI: 10.1016/j.brainres.2017.09.019. View

19.

Wang Y, Liang G, Liang S, Mund R, Shi Y, Wei H . Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer's Disease. Anesthesiology. 2020; 132(5):1062-1079. PMC: 7160009. DOI: 10.1097/ALN.0000000000003224. View

20.

Wu C, Gong W, Wang Y, Sun J, Zhou H, Zhang Z . Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity. Neurobiol Aging. 2018; 67:137-147. DOI: 10.1016/j.neurobiolaging.2018.03.011. View